Intermediate hyperglycaemia

Disease1 paper1 finding

  • Humans1

Upstream

1

Surveillance period (2009-2021)

downin humans1

1 study
  1. surveillance period (2009-2021) decreases intermediate hyperglycaemia in humans (from 24.9% in 2009 to 15.6% in 2021).

    Humansage- and sex-standardised1987 to 2021

    Type 2 diabetes prevalence fell in Mauritius after 2009 · The lancet. Diabetes & endocrinology · 30 Sep 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01
The Lancet Diabetes & EndocrinologyHumans

Type 2 diabetes prevalence fell in Mauritius after 2009

Standardised type 2 diabetes prevalence rose from 14.7% in 1987 to peak at 23.3% in 2009 before falling to 19.9% in 2021.Standardised type 2 diabetes prevalence rose from 14.7% in 1987 to peak at 23.3% in 2009 before falling to 19.9% in 2021.